Clinical trial
Prenatal Exposure to Endocrine Disrupting Chemicals and Risk of Testicular Cancer in Offspring
NCT04848545 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prenatal Exposure to Endocrine Disrupting Chemicals and Risk of Testicular Cancer in Offspring
- Lead sponsor
- Rigshospitalet, Denmark
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- June 1, 2020
- Completion date
- December 31, 2030
- Enrollment
- 700 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
testicular cancer